Koike Kaori, Hashimoto Kenji, Okamura Naoe, Ohgake Shintaro, Shimizu Eiji, Koizumi Hiroki, Komatsu Naoya, Iyo Masaomi
Department of Psychiatry, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan.
Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):517-20. doi: 10.1016/j.pnpbp.2004.01.003.
It is suggested that deficits of alpha 7 nicotinic acetylcholine receptors (nAChRs) might be associated with the cognitive impairments of Alzheimer's disease and schizophrenia, and that agonists for alpha 7 nAChR could be useful for treatment of cognitive dysfunction in these diseases. This study was undertaken to examine the role of alpha 7 nAChRs on hippocampal cellular proliferation of adult mice. The number of 5-bromo-2'-deoxyuridine (BrdU)-immunoreactive cells in the granule cell layer (GCL) and hilus of alpha 7 nAChR heterozygous (+/-) mice was significantly decreased as compared with that of wild-type (+/+) mice. In contrast, the number of BrdU-immunoreactive cells in GCL and hilus of alpha 7 nAChR homozygous (-/-) mice was not different from that of wild-type mice. The results suggest that reduced levels of alpha 7 nAChRs may decrease cell proliferation of adult hippocampus.